Using ELISA, five participants with a history of a COVID-19 infection (two with IgM+IgG, two with IgG only, one with IgM only), and two participants of unknown infection status were positively tested for anti-SARS-CoV-2 antibodies (one with IgM+IgG, one with IgG only). This evidence concerns the gene CD40LG and infection.